Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/09/2008US7462457 Identification of activated receptors and ion channels
12/09/2008US7462451 nucleotides/phosphoramidite linkages; solid phase synthesis
12/09/2008US7462447 mutant SH3-binding protein (SH3BP2) nucleic acids, polypeptides, and agents which selectively bind to the mutant SH3BP2 molecules and which do not bind to the wild type SH3BP2 molecules
12/09/2008US7462360 for induction of interferon/natural killer cell activity; for treating viral/fungal systemic infections, or oncological diseases
12/09/2008US7462358 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen
12/09/2008US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
12/09/2008US7462356 Chimeric papillomavirus-like particles
12/09/2008US7462355 Angiogenesis regulation system
12/09/2008US7462354 Storing a plurality of input parameters in a memory of a computer system, generating a list of epitope pairs from epitopes; determining for each epitope pairs at least one optimum combination of amino acid insertions; identifying
12/09/2008US7462350 cytokine fusion proteins with an increased therapeutic index; able to bind to more than one type of cytokine receptor expressed on cells
12/09/2008CA2432118C Protein s functional assay
12/09/2008CA2229108C A method and kit for evaluating the metastatic tendency of tumors
12/09/2008CA2215203C Vaccines for plague
12/09/2008CA2202652C Production of peptides in plants as viral coat protein fusions
12/09/2008CA2202504C Chimeric conformational epitope peptides
12/09/2008CA2037105C Diagnostic assay for alzheimer's disease
12/04/2008WO2008148108A1 Calcium channel proteins and uses thereof
12/04/2008WO2008147867A2 Cross-linked collagen and uses thereof
12/04/2008WO2008147781A2 Hydrocarbon-producing genes and methods of their use
12/04/2008WO2008147735A1 Identification of adaptive mutations that increase infectivity of hepatitis c virus jfh1 strain in cell culture
12/04/2008WO2008147304A1 A novel neuroprotective peptide
12/04/2008WO2008147187A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
12/04/2008WO2008147186A1 P53 peptide vaccine
12/04/2008WO2008147040A1 Pbz1 protein involved in senescence and cell death of monocot plants
12/04/2008WO2008146854A1 Paratope and epitope of anti-mortalin antibody
12/04/2008WO2008146707A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof
12/04/2008WO2008146272A2 Compositions and methods for treating cxcr6/cxcl16 associated diseases
12/04/2008WO2008146164A2 Streptococcus pneumoniae pilus antigens
12/04/2008WO2008146101A1 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
12/04/2008WO2008146023A1 Vegf-d mutants and their use
12/04/2008WO2008145951A1 Protein layers and their use in electron microscopy
12/04/2008WO2008145865A2 Mutated hyperthermophilic phosphotriesterases and uses thereof
12/04/2008WO2008145761A1 Yield enhancement in plants by modulation of garp transcripton factor zmrr10_p
12/04/2008WO2008145754A2 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
12/04/2008WO2008145749A1 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
12/04/2008WO2008145745A1 Vaccine against hpv
12/04/2008WO2008145721A2 N-terminal modification of polypeptides for protection against degradation by aminopeptidases
12/04/2008WO2008145685A1 Hpv polyepitope constructs and uses thereof
12/04/2008WO2008145664A1 New indications for anti- il-i-beta therapy
12/04/2008WO2008145629A2 Yield enhancement in plants by modulation of maize alfins
12/04/2008WO2008145401A2 Mutated parvovirus structural proteins as vaccines
12/04/2008WO2008145400A2 Mutated structural protein of a parvovirus
12/04/2008WO2008145359A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
12/04/2008WO2008145301A1 Fluorescent proteins and methods of use thereof
12/04/2008WO2008145129A2 Influenza vaccines
12/04/2008WO2008145074A2 Amino acid and nucleic acid sequences and vaccine to control ectoparasite infestations in fish
12/04/2008WO2008145021A1 A truncated l1 protein of human papillomavirus 6
12/04/2008WO2008145020A1 A truncated l1 protein of human papillomavirus 11
12/04/2008WO2008144940A1 Biomarker for hypertriglyceridemia
12/04/2008WO2008144939A1 A process of aqueous protein extraction from brassicaceae oilseeds
12/04/2008WO2008144919A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008WO2008144900A1 A method of enhancing recombinant protein production
12/04/2008WO2008144817A1 Fluorescent protein particles
12/04/2008WO2008124165A3 Self-assembling nanoparticle drug delivery system
12/04/2008WO2008122789A3 Methods for modulating lrrk2
12/04/2008WO2008121127A3 Methods of use of polycomb homologue mel-18
12/04/2008WO2008118936A3 Method of elicting immune response with a modified mva viral hiv-1 vector
12/04/2008WO2008116468A3 Mhc peptide complexes and uses thereof in infectious diseases
12/04/2008WO2008106393A3 Immunogenic compositions and methods for treating and preventing animal infections
12/04/2008WO2008103392A3 Modulation of nkt cell activity with antigen-loaded cdid molecules
12/04/2008WO2008103380A3 Hepatitis b virus compositions and methods of use
12/04/2008WO2008086813A3 Peptides derived from proteins of the insulin super-family
12/04/2008WO2008073578A3 Plant genes involved in nitrate uptake and metabolism
12/04/2008WO2008073441A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/04/2008WO2008070273A3 Methods of expressing lim mineralization protein
12/04/2008WO2008062309A3 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
12/04/2008WO2008059252A3 Methods and composition fro t cell receptors which recognize 5t4 antigen
12/04/2008WO2008056346B1 Anti-angiogenic compounds
12/04/2008WO2008019406A3 A peptide possessing anti-anthrax activity
12/04/2008WO2008013986A3 Compositions and methods for treating or preventing ophthalmic light toxicity
12/04/2008WO2008005063A3 Enabling methods to identify allosteric modulators of receptor activity
12/04/2008WO2007149982A3 Diagnosis of autoimmune disease
12/04/2008WO2007149355A3 Novel peptides that promote lipid efflux
12/04/2008WO2007127198A3 Protein crosslinkers, crosslinking methods and applications thereof
12/04/2008WO2007002026A3 Identification of human t2r recepors that are activated by bitter molecules in coffee (chlorogenic lactones) and related assays for identifying human bitter taste modulators
12/04/2008WO2006031727A3 Peptides for treatment of autoimmune diseases
12/04/2008US20080301826 Novel beta-actin and rps21 promoters and uses thereof
12/04/2008US20080301825 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080300843 Recombinant meso-active thermostable proteins and processes of design and biosynthesis thereof
12/04/2008US20080300385 Covalently-linked complexes of HIV Tat and Env proteins
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300382 Immunogenic Complexes, Preparation Method Thereof And Use Of Same In Pharmaceutical Compositions
12/04/2008US20080300203 Stable Quantitation and Detection of Immune Response Levels with Non-Zero Background Peptides
12/04/2008US20080300190 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating
12/04/2008US20080300188 hybrid Fc; useful as a carrier of biologically active molecules
12/04/2008US20080300187 Mutated hoxb4 proteins with improved stability, and methods of use thereof
12/04/2008US20080300184 Transgenic tieg non-human animals
12/04/2008US20080300183 Gastrointestinal proliferative factor and uses thereof
12/04/2008US20080300181 Methods of using IL-1 antagonists to treat neointimal hyperplasia
12/04/2008US20080300180 Growth Hormone Secretagogue Receptor 1A Ligands
12/04/2008US20080300175 Glycopegylated erythropoietin
12/04/2008US20080300174 Compositions and methods for enhancing factor viii heavy chain secretion
12/04/2008US20080300173 Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
12/04/2008US20080300167 Patched genes and uses related thereto
12/04/2008US20080300163 Modified Human Four Helical Bundle Polypeptides And Their Uses
12/04/2008US20080300137 Polypeptide Extracted from Plants of the Genus Lupinus or Produced in Recombinant Form, Nucleotide Sequence Encoding It and Its Use in animal Nutrition, as a Plant Growth Promoter and in the Fight Against Pathogenic Fungi
12/04/2008US20080299677 New assays for preimplantation factor and preimplantation factor peptides
12/04/2008US20080299644 E.Coli Mutant Containing Mutant Genes Related with Tryptophan Biosynthesis and Production Method of Tryptophan by Using the Same
12/04/2008US20080299642 Vectors with modified protease-dependent tropism
1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 2916